
Warner Bros. Discovery has announced the resignation of two of its board members, Steven Newhouse and Steven Miron, amidst an ongoing antitrust inquiry by the Justice Department.
According to the New York Times, the inquiry is focused on determining whether their simultaneous presence on the board violated federal law, which prohibits corporate officers and board members from serving on the boards of competitors.
Both Newhouse and Miron, executives at Advance, a private family-held business, have decided to step down from their positions on the Warner Bros. Discovery board following the revelation of the investigation, according to NYT. Advance’s portfolio includes the Condé Nast glossy magazine empire and significant shares in Charter Communications, a cable company that competes in the streaming services market, similar to Warner Bros. Discovery.
Read more: Warner Bros Discovery and Paramount Global Face Mounting Concerns Over Proposed Merger
The Justice Department expressed concerns regarding Miron’s and the Newhouse family’s positions on the boards of both Warner Bros. Discovery and Charter, suggesting potential violations of antitrust regulations. Michael Kades, Deputy Assistant Attorney General of the department’s antitrust division, hailed the resignations as a victory for consumers.
Acknowledging the contributions of Newhouse and Miron, David Zaslav, CEO of Warner Bros. Discovery, expressed gratitude for their service while wishing them well in their future endeavors. The resignations mark a significant step in addressing regulatory concerns and ensuring compliance with antitrust laws within the corporate landscape.
Source: NY Times
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas